AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Revenue growth (%)

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.71T
P/E ratio
18.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202519.3+243.75%
Mar 31, 20245.6-67.37%
Mar 31, 202317.2+360.05%
Mar 31, 20223.7-194.67%
Mar 31, 2021-3.9+838.10%
Mar 31, 2020-0.4-191.30%
Mar 31, 20190.5-152.87%
Mar 31, 2018-0.9-80.45%
Mar 31, 2017-4.4-144.23%
Mar 31, 201610.1+41.49%
Mar 31, 20157.1-55.00%
Mar 31, 201415.8+322.46%
Mar 31, 20133.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)